The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluating the diagnostic performance of leptomeningeal diagnosis with CNSide compared to standard cytology.
 
Haley Appel
Honoraria - Accuray (I); BrainLAB (I); Castle Biosciences (I); Elekta (I); Elsevier (I); Kazia Therapeutics (I); Novocure (I); Peerview (I)
Consulting or Advisory Role - Novocure; Novocure (I); ViewRay (I)
Speakers' Bureau - Novocure (I)
Travel, Accommodations, Expenses - Peerview (I)
 
Yazmin Odia
Consulting or Advisory Role - GammaTile; Istari Oncology; PharPoint Research
Research Funding - Bristol-Myers Squibb (Inst); Novocure (Inst)
 
Anshul Saxena
No Relationships to Disclose
 
Mukesh Roy
No Relationships to Disclose
 
Alexander Mohler
No Relationships to Disclose
 
Rupesh Kotecha
Honoraria - Accuray; BrainLAB; Castle Biosciences; Elekta; Elsevier; Kazia Therapeutics; Peerview
Consulting or Advisory Role - Novocure; ViewRay
Speakers' Bureau - GT Medical Technologies (I); Novocure
Research Funding - AstraZeneca (Inst); Blue Earth Diagnostics (Inst); BrainLAB (Inst); Cantex Pharmaceuticals, Inc. (Inst); Exelixis (Inst); GT Medical Technologies (Inst); Medtronic (Inst); Novocure (Inst); ViewRay (Inst)
Travel, Accommodations, Expenses - Elekta; Novocure; Peerview; ViewRay
 
Matthew David Hall
Other Relationship - Proton Therapy Collaborative Group
 
Manmeet Singh Ahluwalia
Stock and Other Ownership Interests - CytoDyn; doctible; MedInnovate Advisors LLC; MimiVax
Honoraria - Elsevier; Peerview; Prime Education; Prime Oncology
Consulting or Advisory Role - Anheart Therapeutics; Apollomics; Bayer; Bugworks; Cairn Therapeutics; Caris Life Sciences; GlaxoSmithKline; InSightec; Janssen; Menarini Group; Modifi Bio; NH TherAguix; Nuvation Bio; Prelude Therapeutics; Pyramid Biosciences; SDP Oncology; ViewRay; Voyager Therapeutics; Xoft
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); MimiVax (Inst); Novartis (Inst); Novocure (Inst); Pharmacyclics (Inst); Seagen (Inst)
 
Minesh P. Mehta
Stock and Other Ownership Interests - Chimerix
Consulting or Advisory Role - Kazia Therapeutics; Mevion Medical Systems; Novocure; Xoft; ZappRx
Patents, Royalties, Other Intellectual Property - WARF patent 14/934,27, TOPICAL VASOCONSTRITOR PREPARATIONS AND METHODS FOR PROTECTING CELLS DURING CANCER CHEMOTHERAPY AND RADIOTHERAPY
(OPTIONAL) Uncompensated Relationships - ViewRay; Xcision Medical Systems
 
Serguei A. Castaneda
No Relationships to Disclose